DEPLOYDatabase

Robot model

Symani Surgical System

surgicalproductionby MMI (Medical Microinstruments)

First-of-its-kind robotic surgical platform for open, soft-tissue microsurgery.

Track Symani Surgical System
Manufacturer
MMI (Medical Microinstruments)
Form factor
surgical
Maturity
production
Lifecycle
active
Deployments
2
Website
mmisymani.com ↗

The verified answer

As of Sep 2026, DEPLOY verifies Symani Surgical System, a surgical by MMI (Medical Microinstruments) (production): 2 verified deployments on record. 1 source back the record.

Overview

First-of-its-kind robotic surgical platform for open, soft-tissue microsurgery. Features NanoWrist instruments — the world's smallest wristed surgical robotic instruments — with 7 degrees of freedom matching the human wrist, tremor filtration, and motion scaling. Enables microvascular repair, lymphatic repair, and peripheral nerve repair on vessels as small as 0.3mm diameter. CE marked in Europe (2019), FDA De Novo authorized in the U.S. (2024).

Verified vs. claimed

Maturity stage
production(Full-scale production deployment with repeat customers.)
Sources on file
View all sources →

Key facts

Manufacturer

MMI (Medical Microinstruments)

Type

Surgical robot

Maturity

In production

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for Symani Surgical System. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (2)

Free to use on your site, with a link back to DEPLOY.

Symani Surgical System on the deployment map

View the global map

Where Symani Surgical System is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Symani Surgical System.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. MMI (Medical Microinstruments) (inferred) · https://www.mmisymani.com

Common questions

What is Symani Surgical System?
First-of-its-kind robotic surgical platform for open, soft-tissue microsurgery. Features NanoWrist instruments — the world's smallest wristed surgical robotic instruments — with 7 degrees of freedom matching the human wrist, tremor filtration, and motion scaling. Enables microvascular repair, lymphatic repair, and peripheral nerve repair on vessels as small as 0.3mm diameter. CE marked in Europe (2019), FDA De Novo authorized in the U.S. (2024).
How much does Symani Surgical System cost?
Symani Surgical System's price is not publicly disclosed. DEPLOY has no verified price on record for Symani Surgical System from MMI (Medical Microinstruments). Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Symani Surgical System actually deployed in the real world?
Yes. Symani Surgical System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Symani Surgical System?
Symani Surgical System is made by MMI (Medical Microinstruments), based in Jacksonville, Florida, USA, founded in 2015.
Where is Symani Surgical System deployed?
2 verified deployments of Symani Surgical System are on the DEPLOY registry, including at Tampa, FL, Florence, Italy.
Can you buy Symani Surgical System?
Symani Surgical System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to Symani Surgical System?
On the DEPLOY registry, comparable surgical robots to Symani Surgical System include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does Symani Surgical System compare to da Vinci (and Ion)?
Symani Surgical System and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Symani Surgical System has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Symani Surgical System a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Symani Surgical System ranks in roughly the top 30% of surgical models tracked by the registry.
What is Symani Surgical System's maturity stage?
Symani Surgical System is at the production stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Production stage means high-volume manufacture and commercial-scale deployments are sustained.
Is Symani Surgical System safe?
Symani Surgical System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: production

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Symani Surgical System.

Recent coverage

Symani Surgical System in third-party press

‘Putting the body back together’ with MMI’s microsurgery robot - MedTech Dive

Jun 17, 2026

First patient treated in US study evaluating robotic-assisted microsurgical intervention for neurodegenerative disease - NeuroNews International

May 15, 2026

MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study - GlobeNewswire

May 4, 2026